132 related articles for article (PubMed ID: 38627898)
21. Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma.
Zhou Y; Jiao J; Yang R; Wen B; Wu Q; Xu L; Tong X; Yan H
Clin Immunol; 2023 Nov; 256():109772. PubMed ID: 37716612
[TBL] [Abstract][Full Text] [Related]
22. Organic Sonodynamic Materials for Combination Cancer Immunotherapy.
Zhang C; Pu K
Adv Mater; 2023 Dec; 35(51):e2303059. PubMed ID: 37263297
[TBL] [Abstract][Full Text] [Related]
23. Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.
Yang Y; Huang J; Liu M; Qiu Y; Chen Q; Zhao T; Xiao Z; Yang Y; Jiang Y; Huang Q; Ai K
Adv Sci (Weinh); 2023 Jan; 10(2):e2204365. PubMed ID: 36437106
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
[TBL] [Abstract][Full Text] [Related]
25. Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.
Ju D; Yamaguchi F; Zhan G; Higuchi T; Asakura T; Morita A; Orimo H; Hu S
Tumour Biol; 2016 Aug; 37(8):10415-26. PubMed ID: 26846106
[TBL] [Abstract][Full Text] [Related]
26. Antitumor Effects of a Distinct Sonodynamic Nanosystem through Enhanced Induction of Immunogenic Cell Death and Ferroptosis with Modulation of Tumor Microenvironment.
Yuan H; Ma J; Huang W; Gong P; Shi F; Xu X; Fu C; Wang X; Wong YK; Long Y; Sun X; Li W; Li Z; Wang J
JACS Au; 2023 May; 3(5):1507-1520. PubMed ID: 37234112
[TBL] [Abstract][Full Text] [Related]
27. A Hybrid Nanomaterial for the Controlled Generation of Free Radicals and Oxidative Destruction of Hypoxic Cancer Cells.
Shen S; Zhu C; Huo D; Yang M; Xue J; Xia Y
Angew Chem Int Ed Engl; 2017 Jul; 56(30):8801-8804. PubMed ID: 28464414
[TBL] [Abstract][Full Text] [Related]
28. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
29. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy.
Kumar A; Chamoto K; Chowdhury PS; Honjo T
Elife; 2020 Mar; 9():. PubMed ID: 32122466
[TBL] [Abstract][Full Text] [Related]
30. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy.
Orafaie A; Sadeghian H; Bahrami AR; Rafatpanah H; Matin MM
Bioorg Med Chem; 2021 Jan; 30():115951. PubMed ID: 33360579
[TBL] [Abstract][Full Text] [Related]
32. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
[TBL] [Abstract][Full Text] [Related]
33. Sonodynamic therapy-assisted immunotherapy: A novel modality for cancer treatment.
Zhang Q; Bao C; Cai X; Jin L; Sun L; Lang Y; Li L
Cancer Sci; 2018 May; 109(5):1330-1345. PubMed ID: 29575297
[TBL] [Abstract][Full Text] [Related]
34. Integrated Nanorod-Mediated PD-L1 Downregulation in Combination with Oxidative-Stress Immunogene Therapy against Cancer.
Wu S; Zhang J; Pan J; Bai S; Wang Z; Chen Y; Xu D; An Y; Liu C; Chu C; Dai Q; Jiang L; Lu Z; Liu G
Adv Healthc Mater; 2023 Jul; 12(17):e2300110. PubMed ID: 36773310
[TBL] [Abstract][Full Text] [Related]
35. Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics.
Zhou L; Huo M; Qian X; Ding L; Yu L; Feng W; Cui X; Chen Y
J Nanobiotechnology; 2021 Apr; 19(1):112. PubMed ID: 33879173
[TBL] [Abstract][Full Text] [Related]
36. Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy.
Huang P; Qian X; Chen Y; Yu L; Lin H; Wang L; Zhu Y; Shi J
J Am Chem Soc; 2017 Jan; 139(3):1275-1284. PubMed ID: 28024395
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
[TBL] [Abstract][Full Text] [Related]
38. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
39. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
[TBL] [Abstract][Full Text] [Related]
40. 5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice.
Li Y; Zhou Q; Hu Z; Yang B; Li Q; Wang J; Zheng J; Cao W
PLoS One; 2015; 10(7):e0132074. PubMed ID: 26161801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
